Houston / Osaka / Austin / Oxford / Milan / Seattle / Emeryville / Washington / DC / Lipid / Cambridge / Sendai / Tsukuba / Gainesville / Brentford / Paris / Stockholm / Shenzhen / Philadelphia / Amsterdam / Nottingham / Shanghai / Dublin / La Jolla / Seoul / Chapel Hill / London / San Diego / Edinburgh / /
Company
Wiley and Sons / Nature America Inc. / Diamyd / Genzyme / Oxford BioMedica / GlaxoSmithKline / Ceregene / Onyx Pharmaceuticals / LG / Genetix Pharmaceuticals / Oak Ridge National Laboratory / Vical / Genethon / IHGT / Bluebird Bio / HSR-TIGET / /
Continent
Europe / /
Country
United Kingdom / China / Israel / Italy / Netherlands / France / Japan / Korea / United States / /
Currency
USD / EUR / pence / /
Event
Bankruptcy / FDA Phase / Product Issues / /
Facility
University of Florida’s Snyder / SaintVincent de Paul Hospital / clinic The / University Paris Descartes SCID-X1 / University of Florida / Necker Hospital / Children’s National Medical Center / University of California / Massachusetts Institute of Technology / Salk Institute / University of North Carolina / In complex / San Raffaele Telethon Institute / University Paris Descartes / University of Pennsylvania / /
IndustryTerm
biotechnology volume / important manufacturing / therapy for Parkinson’s disease / Adherent cell systems / biotechnology / therapy for rare diseases / treatment of debilitating / highly penetrant genetic diseases / gene delivery protocols / treatment for head and neck cancer / vector technology / large pharmaceutical / downstream processing / biotechnology feature / standardized protocols / immune systems / insertion site / manufacturing practices / gas station / plasmid technology / assistive technologies / /
Massachusetts Institute of Technology / Subsequent administration / the University of Pennsylvania / Philadelphia / Children’s National Medical Center / French Muscular Dystrophy Association / Salk Institute / Committee for Human Medicinal Products / Minneapolis Heart Institute Foundation / San Raffaele Telethon Institute for Gene Therapy / Necker Hospital for Sick Children / Oxford University / National Institute of Health / University of North Carolina / European Medicines Agency / US Food and Drug Administration / University of California / Los Angeles / University of Florida / /
Person
Daniel Anderson / Luigi Naldini / Claudio Bordignon / Stuart Naylor / Gaithersburg / Patrick Aubourg / Jean Bennett / Frederic Revah / Marina Cavazzana-Calvo / Alain Fisher / Darren Wolfe / Alessandro Aiuti / Philippe Leboulch / Martin Cline / Jeff Ostrove / Carl June / Timothy Henry / Michael Blaese / Gene Ther / ADA-SCID GT / Leaf Huang / Fulvio Mavillo / Hyde / Sunway Biotech / Robert Langer / Boro Dropulic / Deborah Gill / Richard Snyder / Alain Fischer / Nick Leschly / Jörn Aldag / James Wilson / Ashanti DeSilva / Jesse Gelsinger / /
Position
first external player / freelance writer / CEO / LPL deficiency Filed Aventis Paris Ad5CMV-p53 Head / director and lead investigator / treating head / president and CEO / director / co-leader / chair / CEO of US subsidiary / /